MORGAN SIMPSON: Open Payments
NPI 1548707409 · BROWNSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 52 payments from 11 companies in 2025. Trend: 2023 $162 · 2024 $580 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $194 |
| ABBVIE INC. | 15 | $175 |
| AstraZeneca Pharmaceuticals LP | 8 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $155 |
| Lilly USA, LLC | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Seqirus USA Inc | 1 | $29 |
| Cranial Technologies, Inc | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, FARXIGA, Ozempic, Wegovy, MOUNJARO, AIRSUPRA, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
